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Promoting best gynecologic oncology practice is the
subject of a manuscript from the Society of Gyne-
cologic Oncologists of Canada. This manuscript is
a descriptive report from a meeting that took place
in Montreal involving members of various Canadi-
ans societies interested in the management of pa-
tients with gynecologic malignancies. Although this
manuscript only partly deals with the objectives of
the meeting and does not provide a clinical practice
guideline report (to be reported later), this impor-
tant paper may lead and stimulate other oncologic
societies to embark on similar exercises.
This month’s issue also contains the second part
of a manuscript discussing the merits of naturally
occurring anti-angiogenetic herbal compounds and
their potential relevance to clinical practice. Encour-
agement is offered to explore the potential (and
highly complex) effects in humans through clinical
research. These agents have multiple effects and,
presumably, a potential for multiple benefits.
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The Genitourinary Disease Site Group of the
Cancer Care Ontario Program in Evidence-based
Care undertook a tricky review of the value of maxi-
mal androgen blockade in the treatment of meta-
static prostate cancer. In this issue, the authors note
that many meta-analyses have been published and
yet the magnitude of any benefit remains unclear.
The reported benefits of these agents (including their
small impact on survival) is discussed—together
with the their potentially negative impact on qual-
ity of life.
In discussing the impact of the geometric un-
certainties associated with intensity modulated ra-
diotherapy (IMRT) treatment of head-and-neck
cancers, Ballivy and colleagues address the subject
of variation in target volumes and normal tissues
during this form of radiation therapy delivery. The
issue is not only important and relevant for head-
and neck IMRT, but also for all of radiotherapy as
image guidance becomes the norm.